BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2323651)

  • 21. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
    Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
    Vainionpää L; Kovala T; Tolonen U; Lanning M
    Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
    Henze G; Fengler R; Hartmann R; Kornhuber B; Janka-Schaub G; Niethammer D; Riehm H
    Blood; 1991 Sep; 78(5):1166-72. PubMed ID: 1878583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylaxis of central nervous system leukemia: a case of chronic myeloid leukemia with lymphoid blast crisis treated with imatinib mesylate.
    Thavaraj V; Seth R
    World J Pediatr; 2008 May; 4(2):145-7. PubMed ID: 18661773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764).
    Joyce MJ; Pollock BH; Devidas M; Buchanan GR; Camitta B
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):32-5. PubMed ID: 23211688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
    von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
    Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.
    Fengler R; Hartmann R; Bode U; Janka G; Jürgens H; Riehm H; Henze G
    Haematol Blood Transfus; 1990; 33():511-5. PubMed ID: 2182445
    [No Abstract]   [Full Text] [Related]  

  • 28. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
    Zając-Spychała O; Wachowiak J
    Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Northrup V; Chen L; Nicoletti M; Bostrom B; Stork L; Neglia JP
    J Clin Oncol; 2009 Dec; 27(35):5986-92. PubMed ID: 19884541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of relapsed acute lymphocytic leukemia in adults.
    Freund M; De Boben M; Diedrich H; Ganser A; Heil G; Heyll A; Henke M; Hiddemann W; Knauf U; Koch P
    Haematol Blood Transfus; 1990; 33():432-6. PubMed ID: 2182434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
    Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult acute leukemia.
    Hoelzer D; Büchner T; Gale RP; Zittoun R
    Rev Invest Clin; 1994 Apr; Suppl():21-5. PubMed ID: 7886303
    [No Abstract]   [Full Text] [Related]  

  • 33. Ventral polyradiculopathy with pediatric acute lymphocytic leukemia.
    Anderson SC; Baquis GD; Jackson A; Monteleone P; Kirkwood JR
    Muscle Nerve; 2002 Jan; 25(1):106-10. PubMed ID: 11754193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
    Bleyer WA; Sather HN; Nickerson HJ; Coccia PF; Finklestein JZ; Miller DR; Littman PS; Lukens JN; Siegel SE; Hammond GD
    J Clin Oncol; 1991 Jun; 9(6):1012-21. PubMed ID: 2033414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of childhood acute lymphoblastic leukemia with protocol TCL821: a report of Taiwan Children's Cancer Study Group.
    Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):48-56. PubMed ID: 2666568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Derwich K; Kaczmarek-Kanold M; Wachowiak J; Balcerska A; Balwierz W; Chybicka A; Kowalczyk JR; Matysiak M; Sońta-Jakimczyk D; Wysocki M; Chełmecka-Hanuszewicz L; Jackowska T; Kołtan A; Cwiklińska M; Odój T; Płoszyńska A; Steczowicz M; Wojciechowska V; Wójtowicz A
    Przegl Lek; 2004; 61 Suppl 2():49-52. PubMed ID: 15686046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
    Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G
    Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366
    [No Abstract]   [Full Text] [Related]  

  • 40. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
    Ribeiro RC; Rivera GK; Hudson M; Mulhern RK; Hancock ML; Kun L; Mahmoud H; Sandlund JT; Crist WM; Pui CH
    J Clin Oncol; 1995 Feb; 13(2):333-8. PubMed ID: 7844594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.